Usefulness of defibrotide in the treatment of vascular disorders: a clinical-pharmacologic study.
Di Perri
T
T
Istituto di Clinica Medica-University of Siena, Policlinico LeScotte, Italy.
Laghi-Pasini
F
F
Frigerio
C
C
Capecchi
P L
PL
Messa
G
G
Franchi
M
M
Landini
F
F
Burresi
A
A
Caccatelli
L
L
Ghezzi
A
A
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000328:Adult; D001769:Blood / Q000187:drug effects*; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D001798:Blood Proteins / Q000032:analysis; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005353:Fibronectins / Q000097:blood; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011089:Polydeoxyribonucleotides / Q000008:administration & dosage / Q000494:pharmacology*
D001798:Blood Proteins; D005230:Fatty Acids, Nonesterified; D005353:Fibronectins; D011089:Polydeoxyribonucleotides; C036901:defibrotide; D015121:6-Ketoprostaglandin F1 alpha; D007703:Peptidyl-Dipeptidase A